Synaptic Polarity Depends on Phosphatidylinositol Signaling Regulated by myo-Inositol Monophosphatase in Caenorhabditis elegans

被引:17
|
作者
Kimata, Tsubasa
Tanizawa, Yoshinori
Can, Yoko
Ikeda, Shingo
Kuhara, Atsushi
Mori, Ikue [1 ,2 ]
机构
[1] Nagoya Univ, Dept Mol Biol, Mol Neurobiol Lab, Div Biol Sci,Grad Sch Sci, Nagoya, Aichi 4648602, Japan
[2] CREST, Tokyo 1020075, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
LITHIUM-TREATED RATS; C-ELEGANS; BIPOLAR DISORDER; NERVOUS-SYSTEM; UNIFYING HYPOTHESIS; INOSITOL DEPLETION; NEURONAL POLARITY; CANDIDATE GENE; KNOCKOUT MICE; BRAIN;
D O I
10.1534/genetics.111.137844
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although neurons are highly polarized, how neuronal polarity is generated remains poorly understood. An evolutionarily conserved inositol-producing enzyme myo-inositol monophosphatase ( IMPase) is essential for polarized localization of synaptic molecules in Caenorhabditis elegans and can be inhibited by lithium, a drug for bipolar disorder. The synaptic defect of IMPase mutants causes defects in sensory behaviors including thermotaxis. Here we show that the abnormalities of IMPase mutants can be suppressed by mutations in two enzymes, phospholipase C beta or synaptojanin, which presumably reduce the level of membrane phosphatidylinositol 4,5-bisphosphate (PIP2). We also found that mutations in phospholipase C beta conferred resistance to lithium treatment. Our results suggest that reduction of PIP2 on plasma membrane is a major cause of abnormal synaptic polarity in IMPase mutants and provide the first in vivo evidence that lithium impairs neuronal PIP2 synthesis through inhibition of IMPase. We propose that the PIP2 signaling regulated by IMPase plays a novel and fundamental role in the synaptic polarity.
引用
收藏
页码:509 / U343
页数:21
相关论文
共 50 条
  • [21] Genomic characterization of genes encoding human myo-inositol monophosphatase enzymes.
    Sjoholt, G
    Gulbrandsen, AK
    Lovlie, R
    Molven, A
    Steen, VM
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (06): : 528 - 528
  • [22] In silico study on the substrate binding manner in human myo-inositol monophosphatase 2
    Fujita, Seisuke
    Ohnishi, Tetsuo
    Okuda, Shujiro
    Kobayashi, Ryo
    Fukuno, Satoshi
    Furuta, Daisuke
    Kikuchi, Takeshi
    Yoshikawa, Takeo
    Fujita, Norihisa
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (10) : 2559 - 2567
  • [23] Reversible denaturation of myo-inositol monophosphatase - The stability of the metal-binding loop
    Moreno, F
    Corrales, S
    Blanco, FG
    Gore, MG
    ReesMilton, K
    Churchich, JE
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (02): : 435 - 442
  • [24] Expression and functions of myo-inositol monophosphatase family genes in seed development of Arabidopsis
    Sato, Yuko
    Yazawa, Katsumi
    Yoshida, Seiji
    Tamaoki, Masanori
    Nakajima, Nobuyoshi
    Iwai, Hiroaki
    Ishii, Tadashi
    Satoh, Shinobu
    JOURNAL OF PLANT RESEARCH, 2011, 124 (03) : 385 - 394
  • [25] In silico study on the substrate binding manner in human myo-inositol monophosphatase 2
    Seisuke Fujita
    Tetsuo Ohnishi
    Shujiro Okuda
    Ryo Kobayashi
    Satoshi Fukuno
    Daisuke Furuta
    Takeshi Kikuchi
    Takeo Yoshikawa
    Norihisa Fujita
    Journal of Molecular Modeling, 2011, 17 : 2559 - 2567
  • [26] Li+ Induces Hypertrophy and Down Regulation of Myo-Inositol Monophosphatase in Tomato
    Glenda E. Gillaspy
    Wilhelm Gruissem
    Journal of Plant Growth Regulation, 2001, 20 : 78 - 86
  • [27] Behavioural characterization of Myo-inositol monophosphatase (IMPA2)-deficient mice
    Balemans, W
    Moechars, D
    Kass, S
    Goris, I
    Daneels, G
    Van Craenendonck, H
    Steckler, T
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S71 - S71
  • [28] Myo-inositol monophosphatase is an activated target of calbindin D28k
    Berggård, T
    Szczepankiewicz, O
    Thulin, E
    Linse, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) : 41954 - 41959
  • [29] Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2)
    T Yoshikawa
    M Padigaru
    J D Karkera
    M Sharma
    W H Berrettini
    L E Esterling
    S D Detera-Wadleigh
    Molecular Psychiatry, 2000, 5 : 165 - 171